Press Release Outlook Therapeutics Reports Third Quarter Fiscal Year 2026 Financial Results and Provides Business Update Highlighting FDA Approval of LYTENAVA™ Outlook Therapeutics, Inc. · Aug 14
National - Breaking Oppressive Heat Wave Grips Much of the U.S., Impacting Daily Life and School Year SignalNewsAI · Aug 14
Press Release FREESTYLE DIGITAL MEDIA RELEASES JEFF RYAN’S OFFBEAT GOLF CRIME COMEDY “MOOCH” Written By: EIN Presswire · Aug 14
Press Release Corey Billings to Appear on America’s Top Contractors TV Written By: EIN Presswire · Aug 14
Press Release Fine Art Wildlife Photographer Johan Siggesson Opens Applications for 2026 Wildlife Photography Grant Written By: EIN Presswire · Aug 14
Press Release Nagarro Management Board and Supervisory Board recommend the acceptance of the voluntary public takeover offer by Persistent Nagarro · Aug 14
Press Release Kanen Wealth Management calls for sale of Zevia to Maximize shareholder value Kanen Wealth Management, LLC · Aug 14
Press Release Eucalyptus Resources Announces Submission of Four Highly Qualified Director Nominees at TNR Gold’s Upcoming Annual Meeting Eucalyptus Resources Opportunities Fund 1, LP · Aug 14
Press Release Beyond Meat Announces Effectiveness of 1-for-30 Reverse Stock Split Beyond Meat, Inc. · Aug 14
Press Release Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial Quantum BioPharma · Aug 14
Press Release Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Neumora Therapeutics, Inc. · Aug 14
Press Release Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update Tvardi Therapeutics · Aug 14